nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapy
|
Melikian, Caron |
|
2002 |
24 |
3 |
p. 460-467 8 p. |
artikel |
2 |
A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model
|
Abelson, Mark B. |
|
2002 |
24 |
3 |
p. 445-456 12 p. |
artikel |
3 |
Caspofungin: An echinocandin antifungal agent
|
Stone, Elizabeth A. |
|
2002 |
24 |
3 |
p. 351-377 27 p. |
artikel |
4 |
Dear Dr. Walson:
|
Schoors, Danny |
|
2002 |
24 |
3 |
p. 468-469 2 p. |
artikel |
5 |
Editorial comment
|
Walson, Philip D. |
|
2002 |
24 |
3 |
p. 329- 1 p. |
artikel |
6 |
Effects of Pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: A retrospective review of randomly selected medical records
|
Boyle, Patrick J. |
|
2002 |
24 |
3 |
p. 378-396 19 p. |
artikel |
7 |
“Managing” care: We can't have it all
|
Coons, Stephen Joel |
|
2002 |
24 |
3 |
p. 458-459 2 p. |
artikel |
8 |
Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model
|
D'Arienzo, Peter A. |
|
2002 |
24 |
3 |
p. 409-416 8 p. |
artikel |
9 |
Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: A prospective, randomized, double-blind study versus intramuscular ceftriaxone
|
Legua, Pedro |
|
2002 |
24 |
3 |
p. 434-444 11 p. |
artikel |
10 |
The authors reply
|
Arellano, Felix M. |
|
2002 |
24 |
3 |
p. 469-470 2 p. |
artikel |
11 |
Therapeutic drug monitoring of immunosuppressant drugs in clinical practice
|
Kahan, Barry D. |
|
2002 |
24 |
3 |
p. 330-350 21 p. |
artikel |
12 |
Treatment patterns and associated symptom improvement during six months of care for overactive bladder: A prospective, observational study
|
Boone, Timothy B. |
|
2002 |
24 |
3 |
p. 397-408 12 p. |
artikel |
13 |
Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: A randomized, double-blind, placebo-controlled clinical trial
|
Miner, Cherri |
|
2002 |
24 |
3 |
p. 417-433 17 p. |
artikel |